Genetic testing for forecasting and course of the chronic heart failure against the background arterial hypertension
Abstract
Traced the impact of genetic testing on the course of chronic heart failure in patients with arterial hypertension. Evaluated the clinical significance of the frequency of gene polymorphisms in patients with the chronic heart failure, depending on the success of treatment. All patients were refined risk factors were performed general clinical methods, electrocardiography (ECG), ECG monitoring, echocardiography, pharmacogenetic testing, analysis of outpatient pharmacotherapy for 1 year and 5 years. The use of genetic testing to determine the course of chronic heart failure, its prognosis and timely in view of the personalized approach to carry out the correction of pharmacotherapy in accordance with existing clinical guidelines and standards.
About the Authors
A. L. Khokhlov
Yaroslavl State Medical University
Russian Federation
Russian Federation
Yu. V. Rybachkova
Yaroslavl State Medical University
Russian Federation
Russian Federation
References
1. Atroschenko ES. Patients with chronic heart failure and preserved left ventricular systolic function. Serdechnaya nedostatochnost 2007; 8(6): 297–300 (in Russian).
2. Boytsov SA, Kirichenko PYu, Kuznetsov AE, et al. Study ID polymorphism of the angiotensin-converting enzyme A/C gene polymorphism in type I receptors of angiotensin II in patients with chronic heart failure of various functional classes, developed on the background of coronary artery disease. Serdechnaya nedostatochnost 2006; 4(2): 98–102 (in Russian).
3. Khokhlov AA, Yavorsky AN, Ignatiev VS, Sinitsyna OA, Stepanov IO, Voronina EA, Melnikova YuE. Culture of medication safety. Yaroslavl; 2011 (in Russian).
4. Starodubov VI, Kagramanyan IN, eds. Health Technology Assessment. International experience. Moscow; 2012 (in Russian).
5. Gorbunov VV, Kuzmin AG, Gorbunov EB, Kuzmina OM. Postinfarction remodeling of the left ventricle and the lack of polyunsaturated fatty acids. Serdechnaya nedostatochnost 2011; 12(4): 212–217 (in Russian).
6. Palova TV, Polyakov VP, Duplyakov DV, et al. Distribution of polymorphisms of genes of some components of the hemostatic system in patients with coronary heart disease. Kardiologiya 2009; (4): 9–13 (in Russian).
7. Ageev FT, Belenkov YuN, Fomin IV, et al. Prevalence of chronic heart failure in the European part of the Russian Federation — Data of EPOHA-SN. Serdechnaya nedostatochnost 2006; 7(1): 112–115 (in Russian).
8. Ageev FT, Arutyunov GP, Belenkov YuN. Chronic heart failure. Moscow: GEOTAR Media; 2010 (in Russian).
9. Tereschenko SN, Uskach TM, Akimova OS, Kochetov AG. Chronic heart failure in clinical practice. Serdechnaya nedostatochnost 2004; 5(1): 9–11 (in Russian).
10. Shlyakhto EV, Sitnikova MYu. Modern methods of prognosis in heart failure. Serdechnaya nedostatochnost 2009; 10(6): 322–334 (in Russian).
11. McNamara DM, Tarn SW, Sabolinski ML, et al. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. J Am Coll Ñardiol. 2006; 48: 1277–1282.
12. Goldbergova M, Spinarova L, Spinar J, et al. Association of two angiotensinogen gene polymorphisms, M235T and G(-6)A, with chronic heart failure. Int J Cardiol. 2003; 89(2–3): 267–272.
13. Gasas JP, Cavalleri GL, Bautista LE, et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol. 2006; 164(10): 921–935.
14. Fiuzat M, BristowMR. Pharmacogenetics in heart failure trials. Heart Fail Clin. 2011; 7(4): 553–559.
15. Holmen OL, Romundstad S, Melien O. Association between the G protein 3 subunit C825T polymorphism and the occurrence of cardiovascular disease in hypertensives: The Nord-Trøndelag Health Study (HUNT). Am J Hypertens. 2010; 23(10): 1121–1127.
16. Parsa A, Chang YP, Kelly RJ, Corretti MC, et al. Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci. 2011; 4(1): 17–23.
17. Mant J, Doust J, Roalfe A, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009; 13(32): 1–207.
Review
For citations:
Khokhlov A.L., Rybachkova Yu.V. Genetic testing for forecasting and course of the chronic heart failure against the background arterial hypertension. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2016;(1):56-60. (In Russ.)
Views:
570
Email this article 